Skip to main content

Sub menu

News and events
Contact us
About us

Search

Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

You are here

Home
Resources and guidance
Sponsors

Freyr Australia Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (13)
Prescription medicine registration (3)
Prescription medicine evaluation (1)

Date

2025 (9)
2024 (4)
2023 (4)

Search

Sponsor content

17 result(s) found, displaying 1 to 10

Freyr Australia Pty Ltd - Minimally Invasive Micro Sclerostomy (MIMS) Device - Micro-sclerostomy system handpiece Cancelled under Section 41GL(d) of the Act

13 August 2025

Cancellation by sponsor

Requested by Freyr Australia Pty Ltd
Freyr Australia Pty Ltd - Minimally Invasive Micro Sclerostomy (MIMS) Device - Micro-sclerostomy system control unit Cancelled under Section 41GL(d) of the Act

13 August 2025

Cancellation by sponsor

Requested by Freyr Australia Pty Ltd
Freyr Australia Pty Ltd - Tech in Motion - Jaw physiology evaluation system Cancelled under Section 41GL(d) of the Act

13 August 2025

Cancellation by sponsor

Requested by Freyr Australia Pty Ltd
Freyr Australia Pty Ltd - Single-patient physiologic monitoring system Cancelled under Section 41GL(d) of the Act

11 June 2025

Cancellation by sponsor

Requested by Freyr Australia Pty Ltd
Freyr Australia Pty Ltd - Digital Color Doppler Ultrasound System - Ultrasound system, imaging, general-purpose Cancelled under Section 41GL(d) of the Act

11 June 2025

Cancellation by sponsor

Requested by Freyr Australia Pty Ltd
Freyr Australia Pty Ltd - Electromechanical lithotripsy system, extracorporeal - Electromechanical lithotripsy system, extracorporeal Cancelled under Section 41GL(d) of the Act

11 June 2025

Cancellation by sponsor

Requested by Freyr Australia Pty Ltd
Freyr Australia Pty Ltd - Examination/treatment table, line-powered Cancelled under Section 41GL(d) of the Act

11 June 2025

Cancellation by sponsor

Requested by Freyr Australia Pty Ltd
Freyr Australia Pty Ltd - Medical image management system Cancelled under Section 41GL(d) of the Act

11 June 2025

Cancellation by sponsor

Requested by Freyr Australia Pty Ltd
Freyr Australia Pty Ltd - Nautilus - X-ray system, diagnostic, fluoroscopic, general-purpose, stationary, digital Cancelled under Section 41GL(d) of the Act

3 March 2025

Cancellation by sponsor

Requested by Freyr Australia Pty Ltd
Lobezyl 6 mg/mL solution for injection in pre-filled pen Freyr Australia Pty Ltd

Sep-2024

Prescription medicine evaluation

Active ingredient: Liraglutide.

Pages

Current page 1
Page 2
Next page
Last page

Is there anything wrong with this page?

Help us improve

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.

© Commonwealth of Australia